Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LBVD vs Eupenta+Imovax in healthy infants
NCT04073459Phase 2Unknown
- Sponsor
- LG Chem
- Start
- Nov 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of lomustine + bleomycin + vinblastine + doxorubicin in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by LG Chem. Status: unknown.
02
Drugs
lomustine + bleomycin + vinblastine + doxorubicin
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on NCT04073459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04073459.